HURA
TuHURA Biosciences, Inc./NV
+0.03 (+1.23%)2.06USD46.0K成交股數131M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-13下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | 0.00 | – | – | – | 0.00 | – | – | 0.00 | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 6.6M | 5.2M | 6.1M | 5.0M | 4.9M | 4.6M | 2.9M | 2.8M | 3.6M | 111K | 1.9M | 2.1M |
| 銷售管理費用 | 2.1M | 2.3M | 1.9M | 1.8M | 1.9M | 2.0M | 783K | 796K | 1.0M | 908K | 1.1M | 1.3M |
| 營業利益 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −9.2M-3% | −7.5M+13% | −7.7M+38% | −7.1M+35% | −9.5M+97% | −6.7M+551% | −5.6M+88% | −5.3M+58% | −4.8M | −1.0M | −3.0M | −3.3M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.14-33% | -0.13-13% | -0.13-76% | -0.14-67% | -0.21-48% | -0.15 | -0.54 | -0.43 | -0.40 | – | – | – |
| 稀釋股數 | 64.0M | 60.0M | 47.9M | 50.7M | 44.6M | 43.4M | 12.2M | 12.2M | 12.2M | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 996K | 6.3M | 3.6M | 2.7M | 8.5M | 6.2M | 3.0M | 4.9M | 6.4M | 3.7M | 216K | 1.5M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 31.7M | 29.7M | 27.4M | 25.7M | 34.6M | 14.6M | 4.1M | 6.2M | 7.4M | 4.4M | 1.5M | 4.0M |
| 有息負債 | 3.6M | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 13.2M | 6.5M | 6.4M | 8.9M | 15.2M | 4.8M | 2.4M | 2.4M | 1.5M | 5.9M | 3.5M | 3.2M |
| 股東權益 | 18.5M | 23.2M | 20.9M | 16.8M | 19.4M | 9.9M | −2.8M | −7.0M | −6.1M | −1.6M | −2.0M | 731K |
| 負債比 | 41.7% | 21.9% | 23.5% | 34.7% | 43.8% | 32.7% | 59.1% | 39.4% | 20.5% | 135.7% | 237.2% | 81.6% |
| 淨現金(現金 − 有息負債) | −2.6M | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −4.4M-7% | – | – | – | −4.7M | −1.9M+43% | – | −3.8M | – | −1.3M | – |
| 資本支出 | – | 49K | – | – | – | 43K | – | – | – | – | – | – |
| 自由現金流 | – | −4.5M-7% | – | – | – | −4.8M | – | – | – | – | – | – |
| 折舊攤銷 | – | 23K | – | – | – | 14K | – | – | 34K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | – | −31.0M | –% | -0.63 | −27.7M |
| FY2024 | 0.00 | – | −23.0M | –% | -1.21 | −14.8M |
| FY2024 | – | – | −8.3M | –% | – | – |
| FY2023 | 0.00 | – | −15.0M | –% | -2.47 | −12.0M |
| FY2023 | – | – | −14.6M | –% | – | – |
| FY2022 | – | – | −22.7M | –% | – | −20.6M |
| FY2021 | – | – | −38.3M | –% | – | – |
| FY2020 | – | – | −9.1M | –% | – | – |